Cargando…
Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial
BACKGROUND: Status epilepticus (SE) is an emergency condition for which rapid and secured cessation is important. Phenytoin and fosphenytoin, the prodrug of phenytoin with less severe adverse effects, have been recommended as second-line treatments. However, fosphenytoin causes severe adverse events...
Autores principales: | Nakamura, Kensuke, Marushima, Aiki, Takahashi, Yuji, Kimura, Akio, Asami, Masahiro, Egawa, Satoshi, Kaneko, Junya, Kondo, Yutaka, Yonekawa, Chikara, Hoshiyama, Eisei, Yamada, Takeshi, Maruo, Kazushi, Inoue, Yoshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091776/ https://www.ncbi.nlm.nih.gov/pubmed/33934714 http://dx.doi.org/10.1186/s13063-021-05269-7 |
Ejemplares similares
-
Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for adult convulsive status epilepticus: a multicentre non-inferiority randomised control trial
por: Nakamura, Kensuke, et al.
Publicado: (2023) -
Levetiracetam vs. Fosphenytoin for Second-Line Treatment of Status Epilepticus: Propensity Score Matching Analysis Using a Nationwide Inpatient Database
por: Nakamura, Kensuke, et al.
Publicado: (2020) -
Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus
por: Nakamura, Kensuke, et al.
Publicado: (2017) -
Levetiracetam versus Fosphenytoin in Pediatric Convulsive Status Epilepticus: A Randomized Controlled Trial
por: Handral, Anusha, et al.
Publicado: (2020) -
Comparison of diazepam and lorazepam for the emergency treatment of adult status epilepticus: a systemic review and meta‐analysis
por: Kobata, Hitoshi, et al.
Publicado: (2020)